Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Clearmind Medicine Inc (CMND.CN)

Clearmind Medicine Inc (CMND.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Clearmind Medicine Inc 101-1220 West 6th Avenue Vancouver BC V6H 1A5 CAN

P: 973-536-1016

Description:

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Key Statistics

Overview:

Market Capitalization, $K 7,918
Shares Outstanding, K 39,592
Annual Sales, $ 0 K
Annual Net Income, $ -3,899 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,174 K
60-Month Beta 1.33

Growth:

1-Year Return -69.41%
3-Year Return 0.00%
5-Year Return 0.00%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -0.26
EPS Growth vs. Prev Year 637.25%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 10/03/22

CMND.CN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -471.46%
Return-on-Assets % -439.28%
Profit Margin % 0.00
Net Margin % N/A
Debt/Equity N/A
Price/Sales N/A
Price/Book 4.33
Book Value/Share 0.05
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar